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Abstract  
 
Background In stepped-care models patients typically start with a low intensity evidence-based 
treatment. Progress is monitored systematically and those patients who do not respond adequately step 
up to a subsequent treatment of higher intensity.  Despite the fact that many guidelines have endorsed 
this stepped care principle it is not clear if stepped care really delivers similar or better patient outcomes 
against lower costs compared to other systems. We performed a systematic review and meta-analysis of 
all randomised trials on stepped care for depression. 
Methods We carried out a comprehensive literature search. Selection of studies, evaluation of study 
quality, and extraction of data, was performed independently by two authors.  
Results Fourteen studies were included and ten were used in the meta-analyses (4,580 patients). All 
studies used screening to identify possible patients and care-as-usual as a comparator. Study quality was 
relatively high. Stepped care had a moderate effect on depression (pooled six month between group 
effect size Cohen’s d was 0.34; 95% confidence interval 0.20 to 0.48). The stepped care interventions 
varied a lot in number and duration of treatment steps, treatments offered, professionals involved, and 
criteria to step up.  
Conclusions There is currently only limited evidence to suggest that stepped care should be the 
dominant model of treatment organisation. Evidence on (cost-) effectiveness compared with high 
intensity psychological therapy alone, as well as with matched care, is required.  
 
Keywords: meta-analysis; review; depression; stepped care; collaborative care; self-help; psychological 
treatment 
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Introduction 1 
It is generally acknowledged that care for depression could be improved because the delivery and uptake 2 
of antidepressant medication and evidence-based psychotherapies is often suboptimal (Simon, 2002; Bijl 3 
et al. 2003; National Institute for Health and Clinical Excellence, 2011; Piek et al. 2011; Piek et al. 2012). 4 
Improvement of care is more likely to come from changes in the way care is provided than from adding 5 
new treatment options (Katon & Unutzer, 2006). 6 
Currently, the standard approach in which mental health care is delivered to patients is called 7 
matched care. In this approach the patient is referred to a certain therapist or therapy. The therapy 8 
choice is based (matched) on patients’ characteristics and preferences. As a result, the treatment may 9 
vary (e.g. antidepressant medication or different types of psychotherapy) as well as the setting (primary 10 
care, mental health care, online therapy, group therapy, individual therapy) and the provider (e.g. GP, 11 
nurse, PWP, psychologist, psychiatrist). A major problem with this model at present is our lack of clear 12 
prognostic determinants with which to match patients to the available treatments. It has been argued 13 
that some patients receive too much treatment (Lovell &  Richards, 2000), whilst others too little, as 14 
those lucky enough to be given treatment utilise highly scarce resources to the detriment of many others 15 
who receive little or nothing. 16 
 An alternative approach is called ‘stepped care’.  Within the last ten years and in the context of 17 
international concern regarding the cost and prevalence of common mental health problems, stepped 18 
care has been recommended as a means to increase access and efficiency of mental health care 19 
(Andrews et al. 2006; NICE, 2009). In stepped-care models, the default position is that patients start with 20 
an evidence-based treatment of low intensity as a first step. Progress is monitored systematically and 21 
those patients who do not respond adequately will step up to a subsequent treatment of higher intensity 22 
(Bower & Gilbody, 2005). Low-intensity treatments are usually defined as those treatments that require 23 
less time from a professional than a conventional treatment (Bennett-Levy et al. 2010).  However, 24 
intensity may also mean the time required of patients, cost, and therapists’ level of expertise and it is 25 
possible for treatments to differ in one but not all of these dimensions.  Patients, for example, may 26 
themselves spend similar amounts of time undertaking high- or low-intensity treatments which require a 27 
different amount of time from a professional. 28 
Whilst the concept of intensity readily applies to psychological therapies, it is difficult to 29 
characterise pharmacological and, perhaps, physical treatments as intensive or otherwise.  Given the 30 
widespread use of pharmacotherapy alongside psychological treatment for depression, it is perhaps 31 
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unsurprising that the term ‘stepped care’ is also used to refer to treatment that is not organised in order 1 
of increased intensity; at each ‘step’ patients switch or add treatments of different modalities 2 
(pharmacological, psychological) - patients may start with intensive psychological therapy (Araya et al. 3 
2003; Katon et al. 2004; Ell et al. 2008). 4 
 In practice, self-help treatments (through books or the internet) are often used as a first step in 5 
stepped care. The effectiveness of self-help for depression, guided by a mental health worker but still of 6 
less intensity than traditional psychological therapy, has been demonstrated convincingly (Gellatly et al. 7 
2007; Andrews et al. 2010; Cuijpers et al. 2010; Richards & Richardson 2012). Therefore, the assumption 8 
of stepped care is that for most patients the low intensity treatment will be sufficient and only few will 9 
need a higher intensity treatment, thereby making better use of scarce and expensive resources such as 10 
therapist time. Many depression treatment guidelines have endorsed this stepped care principle e.g. the 11 
English NICE guideline (NHS National Institute for Health and Clinical Excellence, 2009; National 12 
Collaborating Centre for Mental Health, 2010), and the Dutch multidisciplinary guideline (Spijker et al. 13 
2010). This has also led to implementing stepped care in routine practice. The most notable initiative in 14 
this respect is the implementation of the Improving Access to Psychological Therapies (IAPT) programme 15 
(www.iapt.nhs.uk), for which stepped care underpins the organisational structure.  16 
The question remains how much evidence there is for the effectiveness of stepped care. Does 17 
stepped care really deliver similar or better patient outcomes compared to other systems? Although, 18 
observational data from the first year of English IAPT services show that recovery rates were higher in 19 
services making use of the full range of low and high-intensity treatments in stepped care systems (Clark, 20 
2011) no systematic review of randomised trials has been published yet. Therefore, our aim in this study 21 
was to conduct a systematic review and meta-analysis of studies investigating the effectiveness of 22 
stepped care for depression. 23 
 24 
Methods 25 
 26 
Search strategy 27 
We carried out a comprehensive literature search in PubMed, PsycINFO, EMBASE, and the Cochrane 28 
Central Register of Controlled Trials. We combined terms indicative of depression with those of stepped 29 
care, e.g. for Medline we used (depression [Mesh] OR depressive disorder [Mesh] or mood disorders 30 
[mesh]) AND (stepped [all fields] AND care [all fields]). We searched all literature up to April 2012 31 
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without any language restrictions and followed up identified protocol papers published before April 2012 1 
to determine if the researchers had subsequently published their findings before May 2013. Two 2 
independent researchers (AvS and JH) reviewed all abstracts and titles of retrieved references for 3 
eligibility. We retrieved the full papers for all references that had been judged as potentially eligible and 4 
the full papers were examined independently by two of the research team (AvS, JH, DR). In case of 5 
disagreement the paper was discussed with the third reviewer until a consensus was achieved. We also 6 
checked the reference lists of the included papers and a recent meta-analysis on collaborative care 7 
(Archer et al. 2012).  8 
 9 
Inclusion criteria 10 
We used the following inclusion criteria: (1) the study had to be a randomized controlled trial (2) aimed 11 
at adults (3) with a DSM-IV depressive disorder identified through a diagnostic interview, or with 12 
depressive symptoms established by scoring above a cut-off on a depression questionnaire, (4) 13 
investigating ‘stepped care’ as one of the randomised trial groups.  Stepped care had to include 14 
psychological therapy and was defined as the availability of more than one psychological treatment of 15 
different intensities and/or the availability of more than one treatment modality (pharmacological and 16 
psychological).  We defined the intensity of psychological treatments with respect to the time to deliver; 17 
non-psychological (pharmacological) treatments were not characterised in this respect.  We did not 18 
require treatments to be organised in a hierarchy of low- to high-intensity. Decisions about stepping up 19 
had to be based on a systematic clinical evaluation undertaken by a clinician or through questionnaire 20 
assessment, done at a pre-specified time interval and with an explicit aim to determine the next 21 
treatment step. We included studies in which only a proportion of patients were depressed, for example 22 
studies including patients with a common mental health disorder and a sub-group of patients specifically 23 
diagnosed with depression.  We allowed both physical and psychiatric comorbidity.  Studies were 24 
included regardless of their setting or control group. 25 
 26 
Data extraction 27 
We coded the following general characteristics of the studies: year of publication, country, 28 
randomisation level (patient or cluster), the way depression or depressive symptoms were established 29 
(e.g. diagnostic interview or scoring above a cut-off on a questionnaire), possible comorbidity as an 30 
inclusion criterion (e.g. cancer patients, diabetes), age, and total number of patients included in the 31 
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study. The stepped care interventions were coded as follows: number of steps, the content of the 1 
interventions in the different steps, criteria to step up, and total duration of the program. Two 2 
independent assessors coded each study and differences were discussed among the review team until 3 
consensus was reached.  4 
 5 
Quality assessment 6 
We assessed the validity of the studies using the criteria as suggested by the Cochrane Handbook (The 7 
Cochrane Collaboration, 2011): adequate sequence generation, concealment of allocation, blinding of 8 
outcome assessors, adequate handling of incomplete outcome data, selective reporting of data and 9 
other potential threats to validity. Two reviewers conducted the quality assessment independently of 10 
each other.  11 
 12 
Meta-analyses 13 
We calculated between group effect sizes (Cohen’s d) for all individual studies. The effect size represents 14 
the difference between two groups in number of standard deviations (Hedges &  Olkin, 1985; Cooper & 15 
Hedges, 1994).  To calculate between group effect sizes we used the available statistics as published in 16 
the papers (means and standard deviations, mean difference score and 95% confidence interval, or 17 
proportions of patients improved or recovered). When more than one outcome was reported (e.g. more 18 
than one depression questionnaire or more than one cut-off score) we performed a sensitivity analysis. 19 
We pooled the effects using (a) the highest reported effect sizes for all studies and (b) the lowest 20 
reported effect sizes for all studies and (c) the average or combined effect size for all studies.   21 
To calculate the individual effect sizes as well as the pooled mean effect size we used the 22 
computer program Comprehensive Meta-analysis version 2.2.046 for Windows, developed for support in 23 
meta-analysis (www.metaanalysis.com). As we expected considerable heterogeneity, we calculated 24 
pooled effect sizes with the random effects model. However, we first tested heterogeneity under the 25 
fixed effects model using the statistics I2 and Q. I2 describes the variance between studies as a proportion 26 
of the total variance. A value of 0% indicates no observed heterogeneity, and larger values show 27 
increasing heterogeneity, with 25% as low, 50% as moderate, and 75% as high heterogeneity. The 28 
statistical significance of the heterogeneity is tested with the Q statistic. A significant Q value rejects the 29 
null hypothesis of homogeneity. We mark all results in which the p-value is lower than 0.05.    30 
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In addition, we performed subgroup analyses. In these analyses we tested whether there were 1 
significant differences between the effect sizes in different categories of studies. We used the mixed 2 
effects model, which pools studies within subgroups with the random effects model, but tested for 3 
significant differences between subgroups with the fixed effects model. Lastly, publication bias was 4 
tested by inspecting the funnel plot, and by Duval and Tweedie’s trim and fill procedure, which yields an 5 
estimate of the effect size after publication bias has been taken into account (as implemented in 6 
Comprehensive Meta-analysis; Duval & Tweedie, 2000). 7 
 8 
Results 9 
 10 
Inclusion of studies 11 
We retrieved 61 manuscripts for eligibility after screening 438 references (Figure 1). We excluded 47 of 12 
the 61 that did not fulfill our inclusion criteria. In total, we included 14 studies on stepped care for 13 
depression (Unutzer et al. 2002 [13]; Araya et al. 2003 [2]; Katon et al. 2004 [10]; Ell et al. 2008 [7]; Van't 14 
Veer-Tazelaar et al. 2009 [14]; Bot et al. 2010 [3]; Davidson et al. 2010 [4]; Ell et al. 2010 [8]; Patel et al. 15 
2010 [11]; Seekles et al. 2011 [12]; Apil et al. 2012 [1]; Dozeman et al. 2012 [6]; Davidson et al. 2013 [5]; 16 
Huijbregts et al. 2013 [9]). In one trial [3], only part of the results were published and we contacted the 17 
authors to obtain the (unpublished) research protocol and additional data. 18 
We included ten of the 14 studies in our quantitative meta-analyses on the treatment of 19 
depression in which outcomes were expressed as the reduction of depressive symptoms. One treatment 20 
trial was excluded from this analysis because the authors did not report post–treatment data but only 21 
long-term follow-up.  The three remaining trials were aimed at prevention of depression, either as 22 
indicated prevention [6,14] or as relapse prevention [1] with the incidence of depressive disorders as the 23 
main outcomes. Given that it is not useful to pool results from treatment and prevention we excluded 24 
the prevention trials from our quantitative meta-analyses.    25 
 26 
Characteristics of the 14 included treatment and prevention studies 27 
The 14 studies included a total of 5,194 patients of whom 2,560 were randomized to stepped care and 28 
2,634 to a control condition. For the ten studies included in the quantitative meta-analyses the total 29 
number of included patients is 4,580 with 2,243 in the stepped care arms and 2,337 in the control 30 
conditions (Table 1).   31 
6 
 
Twelve trials were patient-randomised [1-8,10, 12-14], and two were cluster-randomised [9, 11]. 1 
Six trials were conducted in the US [4-5,7-8,10,13], six in The Netherlands [1,3,6,9,12,14], one in Chile [2] 2 
and one in India [11].  Participants were recruited mainly from primary care [2,9-11,12-14], or secondary 3 
care [3-5,7]. All studies compared stepped care to usual care, either standard [1-6,9-10,12-14] or 4 
‘enhanced’ [7-8,11].  5 
Five of the treatment trials [3-5,8,10] included patients scoring above a cut-off on a self-rated 6 
depression questionnaire only (two also used the core symptoms of MDD) while five others [6,9,11-13] 7 
performed diagnostic interviews to include patients with MDD (one also included minor depression, and 8 
two also included dysthymia). The three prevention trials [1,6,14] used a diagnostic interview to exclude 9 
patients with MDD. Six of the studies were aimed at depressive symptoms among patients with either 10 
co-morbid acute coronary syndrome [4-5], cancer [7] or diabetes mellitus [3,8,10] and five trials, 11 
including the three prevention studies, were specifically aimed at older adults [1,3,6,13,14].  12 
 13 
Characteristics of the stepped care interventions 14 
We found considerable between study heterogeneity in numbers of steps (two, three or four), types of 15 
treatments offered at each step, and duration of the total intervention (between three and 12 months; 16 
table 2).   17 
Seven studies [4, 5,7-10,13], six of which were US trials, were based on the ‘IMPACT’ model and 18 
used Problem Solving Treatment (PST) and antidepressant medication (ADM) as the core of the 19 
intervention. The IMPACT intervention is primarily a collaborative intervention in which a dedicated 20 
team works together to provide optimal depression care, meeting our inclusion criteria as a stepped care 21 
approach because patients were evaluated at predetermined time intervals according to defined 22 
improvement criteria and care was adjusted or augmented if the patient did not improve sufficiently. 23 
Treatments were provided according to patients’ needs and preferences.  In all seven ‘IMPACT’ studies 24 
and one other involving both psychological treatment (psycho-education) and ADM [2], there was no 25 
progression of increasing therapeutic intensity.   26 
In contrast, care was delivered in the other six trials [1,3, 6,11-12,14] through steps of increasing 27 
intensity. Five of the six studies started with watchful waiting although two studies [12,14] only included 28 
patients after the watchful waiting period while the other  three [1,3,6] included watchful waiting as part 29 
of their stepped care model. The first therapeutic component included psycho-education or 30 
bibliotherapy alone or combined, offered either as self-help (with online, telephone or face-to-face 31 
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support), in a group, or as individual sessions. The next step in these six studies varied widely and 1 
included psychological therapy (CBT, life review, IPT, PST, Coping with Depression Course) [1,3,6,12,14] 2 
or a psychological therapy (IPT) combined with ADM[11]. The last step typically consisted of referral to 3 
specialists, a GP or mental health services. Only two of those six studies which used steps of increasing 4 
intensity are included in the quantitative meta-analysis [11,12]. As mentioned above, one study was 5 
excluded because of unavailability of post-test data [3], and the three other trials were aimed at 6 
(relapse) prevention [1,6,14].  7 
 In twelve studies more than one healthcare professional was involved in stepped care [1-2,4-13] 8 
including nurses [1-2,4-6,10,12-13], psychiatrists [4-5,7-11,13], General Practitioners [2,5,8,9,11,13], 9 
social workers [2,4,7-8], psychologists [4-5,12-13] and relatively less qualified staff (residential home 10 
staff [6], an assistant patient navigator [8], lay health counselor [11] and study researcher [1]).  In two 11 
studies, treatment was provided by one healthcare professional: a nurse or psychologist [3] or a nurse 12 
only [14].  No details are available for external professionals providing treatment after referral outside 13 
the core stepped care team.  14 
Patient progress was assessed using one [1-7,9-11,13-14], two [8] or three [12] self-rated 15 
instruments.  In five studies the decision to ‘step up’ was contingent on patients’ score relative to a 16 
specific cut-off on the HDRS [2], CES-D [1,14], PHQ-9 [7] or HADS, IDS and WSAS [12].  In five studies the 17 
decision to ‘step up’ was dependent on improvement (relative to baseline or the last assessment) on the 18 
PHQ-9 [4-5,10,13] or CES-D [6]. Three studies used a combination of improvement and a specific cut-off 19 
on the CES-D [3], PHQ-9 [9] or PHQ and SCL [8].  In one study [11] improvement was assessed by health 20 
counselors following application of the GHQ with no further detail specified. 21 
 22 
Quality of the included studies 23 
In one study [3] we rated all quality criteria as either unclear or at high risk of bias and in a second [1] we 24 
rated five of the six criteria as unclear or at high risk of bias.  For the remaining twelve studies quality on 25 
most criteria was high. The description of randomisation sequence generation was adequate but four of 26 
these twelve studies did not clearly report methods of allocation concealment [4,10,11,14]. No studies 27 
were able to blind patients or clinicians but all studies used assessors to measure outcomes who were 28 
unaware of the randomisation status of the patients or used self-report. Post-intervention study drop-29 
out ranged between 8.0% [5] and 49.6% [3] and one study [9] was rated at high risk of bias with respect 30 
to handling incomplete outcome data. All studies used intention-to-treat analyses. Three of the twelve 31 
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studies were at high risk of other biases because of the potential for contamination between trial arms 1 
[6,8,13] or because patients were recruited in different ways in the intervention and control groups [9]. 2 
 3 
Effects of stepped care 4 
Most of the studies used more than one depression outcome measure so we averaged the between 5 
group differences from the various measures as a single combined measures effect size for each study 6 
(Table 3). We found an overall post-intervention effect size of d = 0.38 (95% CI 0.18 to 0.57).  We also 7 
examined the post-test effect sizes from the measure with the highest effect size for each study (d = 8 
0.42; 95% CI 0.22 to 0.62) and repeated this with the measure producing the lowest effect sizes (d = 9 
0.33; 95% CI 0.13 to 0.52). All effect sizes were significantly in favour of stepped care.  10 
 The stepped care interventions varied in duration between three and 12 months. We used the 11 
combined measures effect size to examine outcomes at different time points. The effects were d = 0.57 12 
at two to four months (95% CU 0.21 to 0.94), d=0.34 at six months (95% CI 0.20 to 0.48), d=0.43 at nine 13 
to 12 months (95% CI 0.20 to 0.65), and d = 0.26 at 18 months (one study only). All effects were 14 
significantly in favour of the stepped care intervention with the exception of the 18 month result. 15 
Heterogeneity, as indicated by I2, was high for the post-intervention effect sizes as well as for the effect 16 
sizes at the different time points. From Figure 2 it can be observed how the six month effect sizes varied 17 
between the different studies. To examine this heterogeneity we performed subgroup analyses. 18 
 19 
Subgroup analysis and publication bias 20 
We analysed the association of the six months outcomes (overall d = 0.34; Table 3) with the following 21 
variables: country in which the study was performed (USA, Netherlands, or other), treatment based on 22 
IMPACT protocol (yes or no), stepped care treatment using progressive intensity (yes or no), physical 23 
health comorbidity (present or absent), and diagnostic status at inclusion (diagnosis assessed or not). 24 
The effect of the eight studies on stepped care models without progressive intensity was significantly 25 
higher (d=0.41) than those of the two studies examining stepped care models with progressive intensity 26 
(d=0.07; p < 0.01). None of the remaining variables were significantly related to the effect size. Even 27 
though not statistically significant (p=0.63) the effect size for the two Dutch studies was lower (d=0.18) 28 
than for those conducted in the USA (d=0.38) or other countries (d=0.44).  29 
 We found no indication of publication bias in our funnel plot on the six month outcomes or in 30 
Duval and Tweedie’s trim and fill procedure. No studies needed to be imputed. 31 
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 1 
Effects of stepped care intervention for depression:  four studies excluded from the quantitative 2 
analyses 3 
The treatment study of Bot [3] only provided two year follow-up data for the complete cases (49.6%) and 4 
reported no difference between the groups (d=-0.12; 95% CI -0.62 to 0.39). Both of the trials on 5 
indicated prevention showed results in favour of stepped care [6, 14]. One [6] demonstrated 12 month 6 
MDD rates of 6.5% in the intervention group and 14.1% in the control group (Incidence Rate Ratio = 0.46; 7 
95% CI 0.17 to 1.21). The other [14] demonstrated 12 month prevalence rates of combined MDD and 8 
anxiety disorders of 11.6% in the intervention group and 23.8% in the control group (Incidence Rate 9 
Ratio = 0.49; 95% CI 0.24 to 0.98). The pooled rate ratio of the two studies was 0.48 (95% CI 0.27 to 0.83; 10 
I2 = 0).  The study on relapse prevention [1] reported no difference in the 12 month MDD incidence rate 11 
between stepped care and care-as-usual.  12 
 13 
Discussion 14 
We identified 14 trials on stepped care for depression, ten of which could be used in a meta-analysis of 15 
treatment outcomes. Stepped care has a moderate effect on depression (d=0.34 at six months and 16 
d=0.38 post-intervention). Stepped care interventions based on progressive treatment intensity 17 
performed worse (n=2; d=0.07) than those without a clear intensity order (n=8; d=0.41; p < 0.01). Most 18 
trials were of good quality. The stepped care interventions were extremely heterogeneous with different 19 
numbers of steps, different treatment components, different duration of the steps, different rules about 20 
stepping up and different professionals involved.  21 
 Even though we demonstrated that stepped care is effective, the effect sizes were modest. 22 
Meta-analyses have demonstrated higher effect sizes (Cohen’s d between 0.42 and 0.88) for self-help 23 
interventions which are usually considered as a first step in stepped care (Gellatly et al. 2007; Andrews et 24 
al. 2010;  Richards & Richardson 2012, Bower et al. 2013). However, the majority of the trials on self-25 
help have been performed in population samples rather than in clinical samples.  Even though baseline 26 
severity of symptoms do not seem to be associated with the effect of self-help interventions (Bower et 27 
al. 2013) there might be other differences between clinical and population samples which might account 28 
for differences in effects.  29 
The stepped care six month effect size (d=0.34) was similar to the one found in the Cochrane 30 
review on collaborative care (Archer et al. 2012).  (Collaborative care may include a broad range of 31 
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interventions, settings and providers; defining characteristics are that a team of health care professionals 1 
are responsible for providing the ‘right’ care at the ‘right’ time and that there is a structured 2 
management plan which includes scheduled patient follow-ups (Bower et al. 2006; Gunn et al. 2006).)  3 
This finding may not be suprising given that six out of the ten studies [2,7 8,10,11,13] included in our 4 
meta-analysis were also included in the meta-analysis of collaborative care. 5 
In stepped care the primary focus is on psychological interventions of different intensity.  6 
However, as we noted in our introduction, it is unclear how medication management, which might be 7 
offered with significant support from case managers, fits into stepped care programs. Since medication 8 
management is an important treatment option in depression care, we decided to include it in our 9 
definition of stepped care (the availability of more than one treatment modality, medication and 10 
psychotherapy).  This choice led to the inclusion of several of the collaborative care trials, albeit the 11 
majority of which were also described as stepped care [2, 7, 8, 10, 11], and three other studies [4, 5, 9] in 12 
which stepped care was not defined by a progressive increase in treatment intensity.  Our definition is 13 
debatable: others may choose to review or conduct future research on stepped care in line with how it 14 
was originally conceived; findings based on one definition of stepped care may not generalize to the 15 
other; future research may be required to compare stepped care defined by a progressive increase in 16 
treatment intensity and stepped care that is not.  17 
We compared the results of the eight studies without a hierarchy in treatment intensity with the 18 
two studies which did provide ‘true’ stepped care with increasing treatment intensity. This comparison 19 
demonstrated that the ‘true’ stepped care studies performed significantly worse. This indicates that it 20 
might be better to match the first treatment to the patient’s need than to offer a low intensity treatment 21 
regardless of the patient’s clinical profile. However, we think that this conclusion would be premature. 22 
First, because the results of ‘true’ stepped care are based on two studies only. Second, because seven of 23 
the eight studies without increasing intensity were based on the IMPACT protocol. Those seven IMPACT 24 
studies did not show better results than the three non-IMPACT studies. In other words, the difference in 25 
results between the two subgroup analyses (IMPACT vs. non-IMPACT, and increasing intensity vs. no 26 
increasing intensity) was actually based on one study with a very high effect size [2]. Third, because the 27 
two studies aiming at prevention of (indicated) depression both offered ‘true’ stepped care and they 28 
demonstrated very large effects (almost halving the incidence of depression). In conclusion we think that 29 
more ‘true’ stepped care studies need to be performed before we can reach a definite conclusion. 30 
Moreover, it is important not only to look at treatment studies but also prevention studies especially as 31 
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it has been argued that prevention contributes most in reducing the global burden of depression 1 
(Cuijpers et al. 2012). This and other key areas for future research are summarised in Box 1. 2 
The central tenet of stepped care is that for many patients the first (low intensity) treatments 3 
are sufficient and relatively few patients need to step up. This means that similar (or better) patient 4 
outcomes could be achieved against lower costs. In the current meta-analyses only a limited number of 5 
trials provided data on the proportion of patients recovered after the first treatment. The data that was 6 
available was hard to interpret since the definition of adequate recovery varied between the studies as 7 
well as the duration of the steps, the number of patients dropping out of treatment and the number of 8 
patients not reporting health status. We also do not know how many patients needed to step up or the 9 
actual percentage of patients who took up this second step. This is important information because within 10 
stepped care there is a risk that patients do not start a second higher intensity treatment after failure of 11 
the first.  To improve reporting on clinical trials of stepped care for depression, we identify data that are 12 
important to include (Box 2); including this would maximize subsequent systematic reviews. 13 
 We did demonstrate that better outcomes were reached in stepped care compared to care-as-14 
usual. However, the question is whether or not care-as-usual is the best comparator. One could argue 15 
that care-as-usual is similar to matched care since this is the current dominant treatment approach.  16 
However, all the trials used an active approach to find and select patients. In four trials it was reported 17 
that the GP was informed about the diagnostic status of the patients in the control group, while the 18 
other studies refrained from informing the GP or did not report how they handled this. This indicates 19 
that care-as-usual probably more closely resembled ‘no care’. In other words we demonstrated that 20 
stepped care is better than doing nothing. The ideal test, against true matched care or against high 21 
intensity care for all patients, has not been performed yet.  We identified five (Dutch) protocol 22 
manuscripts on stepped care (Braamse et al. 2010; Krebber et al. 2012; Pommer et al. 2012; Van Dijk et 23 
al. 2012; Van der Weele et al. 2012); none compare stepped with matched care or with intensive 24 
psychological treatment for all.   25 
The remaining assumption of stepped care is that it reduces health care costs. Six out of the ten 26 
studies included in the meta-analyses published a separate paper on the cost-effectiveness of their 27 
(collaborative) stepped care program (Katon et al. 2005; Araya et al. 2006; Simon et al. 2007; Van ‘t Veer-28 
Tazelaar et al. 2010; Butorff et al. 2012; Hay et al. 2012; Ladapo et al. 2012). The results of the studies 29 
performed in Chile and India are hard to generalize to the Western world. The remaining four (US) 30 
papers either report savings or incremental costs which are offset by the health gains. This means that 31 
12 
 
there is an indication that stepped care interventions might indeed be more cost-effective. However, 1 
because stepped care has not been compared to either matched care or high intensity care, final 2 
conclusions about cost-effectiveness cannot be made. 3 
 Our study has several limitations. First is the limited number of studies. This made it especially 4 
hard to perform subgroup analyses. In this respect, the five protocol manuscripts on stepped care are 5 
relevant, indicating that there is considerable clinical trials work in progress. Second, the stepped care 6 
interventions varied a lot as well as the samples included in the studies (countries, with or without 7 
comorbidity, age, definitions of depression etc). This may limit the generalizability of our findings.  A 8 
strength of this study is that it is the first to systematically describe all the available evidence with 9 
respect to stepped care which is regarded in many countries as the preferred way to offer depression 10 
care. Furthermore, most of the studies were of good quality.  11 
 Although many guidelines recommend stepped care, there is currently only limited evidence to 12 
suggest it should be the dominant model of treatment organization compared to alternative systems. 13 
Consistent with a previous observational study (Richards et al. 2012), we found considerable variety in 14 
the implementation of stepped care (with respect to the number and duration of treatment steps, 15 
treatments offered, professionals involved and criteria to step up) and only one significant difference 16 
between subgroups of studies (progressive intensity, yes/no) which requires further research.  Hence, it 17 
was not possible to identify any optimal component of stepped care or to suggest a preferred model for 18 
delivery which may be associated with increased effectiveness.  It was also not possible to determine 19 
with any certainty the relative effectiveness of stepped care models defined by combined treatment 20 
modalities (psychological and pharmacological) compared to those defined by progressive intensity of 21 
psychological treatment. The balance of costs, effectiveness and acceptability has not been investigated 22 
and further research is needed to determine if stepped care really should have such prominence in 23 
treatment guidelines. The first stage of such a research programme should be a fully powered clinical 24 
trial of stepped psychological versus high-intensity treatment to test both the non-inferiority hypothesis 25 
and the potential cost advantages of stepped versus more intensive treatment.  26 
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Figure 1. Flow-chart of studies included in the meta-analysis on stepped care for depression 
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 Secondary analysis (n=8) 
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 Separate cost-effectiveness paper (n=5) 
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(n =  14 ) 
Studies included in quantitative synthesis  
(meta-analysis) (n =  10 ) 
Excluded for quantitative synthesis because: 
 Prevention trial (n=3)  
 insufficient data available (n=1) 
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Figure 2. Effects of stepped care versus care-as-usual (6 months outcomes) 
 
Study name Outcome Time point Statistics for each study Std diff in means and 95% CI
Std diff Lower Upper 
in means limit limit
Araya, 2003 Combined 6 months 0,839 0,530 1,148
Davidson, 2010 BDI 6 months 0,485 0,168 0,803
Davidson, 2013 Combined 6 months 0,443 0,057 0,828
Ell, 2008 Combined 6 months 0,196 -0,041 0,433
Ell, 2010 Combined 6 months 0,369 0,108 0,630
Huijbregts, 2013 Combined 6 months 0,455 -0,120 1,031
Katon, 2004 Combined 6 months 0,238 -0,030 0,506
Patel, 2010 Combined 6 months 0,073 -0,091 0,237
Seekles, 2011 IDS 6 months 0,031 -0,326 0,389
Unutzer, 2002 Combined 6 months 0,419 0,309 0,528
0,339 0,197 0,481
-1,00 -0,50 0,00 0,50 1,00
care-as-usual stepped care
Figure 2
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Table 1. Characteristics of randomized controlled trials comparing stepped care for depression with usual care 
ID Author Year Country Random 
level 
Target of the 
trial 
Control condition Depression criteria Comorbid 
disorder 
Age 
(years) 
IMPACT 
based 
Total N  
(EXP / CTRL) 
1 Apil 2012 Nether 
lands 
Patient Prevention Usual care: depressive 
symptoms monitored. 
Not depressed (MINI) - 55+ No 136
1
 (74/62) 
2 Araya 2003 Chile Patient Treatment Usual care: GPs given 
guidelines on depression 
treatment. 
 
MDD (MINI) - 18-70 No 240 
(120/120) 
3 Bot 2010 Nether 
lands 
Patient Treatment  Usual care: ADs or 
psychotherapy were 
available. 
 
Depressive symptoms 
(CES-D ≥ 16) 
Diabetes 55+ No 123
1 
(64 / 
59) 
4 Davidson 2010 USA Patient Treatment  Usual care: physicians 
informed of patients’ 
depressive symptoms/ 
MDD criteria. 
 
Persistent depressive 
symptoms (BDI ≥10 and < 
45 at week 1 and 13) 
Acute Coronary 
Syndrome 
NS
3
 Yes 157 (80/77) 
5 Davidson 2013 USA Patient Treatment Usual care: PCPs and/or 
cardiologists informed of 
patients' depressive 
symptoms. 
 
Depressive symptoms (BDI 
≥ 10 on 2 occasions or ≥ 15 
on 1 occasion, 2 to 6 
months after 
hospitalization for ACS) 
 
Acute Coronary 
Syndrome 
35+ Yes 150 (73/77) 
6 Dozeman 2012 Nether 
lands 
Patient Prevention Usual care 
4
 Depressive symptoms 
(CES-D ≥ 8), no MDD 
(MINI) 
- Elderly in 
residential 
homes 
No 185
1
 (93/92) 
7 Ell 2008 USA Patient Treatment  Enhanced usual care: 
patient/family 
depression and cancer 
educational pamphlets + 
resource list. 
5
 
 
1 or 2 core depressive 
symptoms, and PHQ  ≥ 10,  
and/or 2 questions from 
the SCID indicating 
dysthymia 
Cancer 18+ Yes 472 
(242/230) 
8 Ell 2010 USA Patient Treatment  Enhanced usual care:  
depression educational 
pamphlets + resource 
list; PCPs informed of 
patient depression 
diagnoses. 
 
Depressive symptoms 
(PHQ ≥ 10 and 1 or 2 core 
symptoms) 
Diabetes 18+ Yes 387 
(193/194) 
Table 1
Click here to download Table(s): Table 1 characteristics studies.docx 
9 Huijbregts 2013 Nether 
lands 
Cluster Treatment Usual care: patients 
informed of diagnosis 
and advised to consult 
GP. 
 
MDD (MINI) and PHQ ≥ 10 - 18+ Yes 150 (101/49) 
10 Katon 2004 USA Patient Treatment  Usual care:  patients 
advised to consult PCP. 
Persistent depressive 
symptoms (PHQ  ≥ 10 and 
mean SCL  ≥ 1.1  at 2 
weeks) 
 
Diabetes NS
3
 Yes 329 
(164/165) 
11 Patel 2010 India Cluster Treatment  Enhanced usual care: 
physicians & patients 
given screening results 
and a treatment manual. 
 
MDD (CIS-R) and GHQ > 5 - 18+ No 774
2
 
(304/470) 
12 Seekles 2011 Nether 
lands 
Patient Treatment  Usual care: patients 
advised to consult GP 
Persistent depressive 
symptoms (K10 ≥ 21 at 
week 1 and 4), MDD, 
dysthymia, minor 
depression (CIDI) 
 
- 18-65 No 120 (60/60) 
13 Unutzer 2002 USA Patient Treatment  Usual care 4 MDD or dysthymia (SCID) - 60+ Yes 1801 
(906/895) 
14 Van ‘t Veer 2009 Nether 
lands 
Patient Prevention Usual care 
4
 Persistent depressive 
symptoms (CES-D ≥ 16 at 
week 1 and 13), no MDD 
or anxiety disorder (MINI) 
 
- 75+ No 170
1
 (86/84) 
Notes:  1 not included in quantitative meta-analysis; 2 total N in this trial is 2796 but we only used the depressed subsample in our meta-analysis; 
3 age in- and exclusion criteria ‘not specified’; 4 no particular feature of usual care described; 5 oncologists may have attended a depression 
treatment didactic session by the study psychiatrist at the start of the study and yearly after and may have been informed of patients' 
depression status although it is unclear whether these features applied to patients in the Enhanced Usual Care group.  
Abbreviations: GP – General Practitioner; PCP Primary Care Physician; MDD – Major Depressive Disorder; ACS – Acute Coronary Syndrome; GHQ 
– General Health Questionnaire; other abbreviations refer to depressive symptom checklists (CES-D, BDI, PHQ, SCL) and diagnostic interviews for 
depression (MINI, CIS-R, SCID, CIDI). 
Table 2. Characteristics of the stepped care interventions for depression 
ID Author N 
step 
Step 1 Step 2 Step 3 Step 4 Providers
1 
Stepping up rules Total 
duration 
1 Apil 4 Watchful waiting (1 phone 
call) 
Bibliotherapy based on 
CWD (3 phone calls) 
Individual CWD course 
(12 sessions) 
Referral to a GP or 
psychotherapist 
Nurse, Researcher CES-D >=16 at 6 
weeks, 3 months and 
6 months 
6 months 
2 Araya 2 PE group (9 sessions) + 
self-help book. If HDRS > 
19 also  structured ADs 
Initiating or adjusting ADs -  Social workers, 
nurses, GP 
HDRS > 12 at 6 weeks 3 months 
3 Bot 4 Watchful waiting + 3 
phone  
Bibliotherapy based on 
CWD (3 phone calls)  
CBT: 4 modules of CWD 
course (5 sessions) 
Referral to 
psychiatrist 
Prevention worker 
(nurse or 
psychologist) 
CES-D improvement < 
5 or CES-D ≥ 16 at 6, 
12 & 24 weeks 
 
36 weeks 
 8 
months 
4 Davidson 
2010 
3 PST (no predetermined 
number of sessions) or 
ADs (patient preference) 
Switching treatments, 
adding treatments, 
intensifying original 
treatment (patient 
preference) 
Referral to usual care 
provider  
- nurse, psychologist, 
social worker, 
psychiatrist 
Initial PHQ9 5-10 and 
improvement < 30%; 
initial PHQ9 11-20 
and improvement < 
50%; initial PHQ9  > 
20 and improvement 
< 60%.  Assessed 
every 8 weeks. 
 
6 months 
5 Davidson 
2013 
4 PST (number of sessions 
not specified) and/or Ads, 
or neither 
Switching treatments,  
adding treatments  
(patient preference) 
Switching treatments,  
adding treatments  
(patient preference) 
Switching treatments,  
adding treatments  
(patient preference) 
PST therapist, 
psychiatrist, clinical 
psychologist, GP or 
advanced practice 
nurse 
See Davidson 2010. 
Assessed every 6-8 
weeks. 
 
6 months 
6 Dozeman 4 Watchful waiting Bibliotherapy based on 
CWD (face-to-face 
guidance; no 
predetermined number 
of sessions) 
Individual face-to-face 
Life Review (no 
predetermined number 
of sessions) + advise to 
consult GP  
If CESD ≥ 16: advised 
to consult GP or 
referral to mental 
health specialist  
Residential home 
staff, mental health 
nurses 
CES-D improvement < 
5 at 1 & then every 3 
months. 
10 
months 
7 Ell 2008 3 1 visit CDCS then PST (8 to 
12 sessions) and/ or ADs 
(patient preference) 
ADs and additional 
psychotropic medications 
Referral to usual care 
provider / public safety 
net clinic 
- Social workers 
(Cancer Depression 
Clinical Specialist),  
psychiatrist 
PHQ9 ≥ 10.  Timing 
unclear. 
12 
months 
  
Table 2
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8 Ell 2010 3 PST (number of sessions in 
this step not specified) or 
ADs (patient preference) 
PST in step 1: addition of 
pharmacotherapy; ADs in 
step 1: change of ADs or 
adding PST (patient 
preference) 
Additional PST,  adding 
insomnia medication, 
referral to specialty 
mental health care. 
- Social work diabetes 
depression clinical 
specialists, GP, 
psychiatrist, assistant 
patient navigator 
Partial or non-
response: clinical 
improvement = SCL or 
PHQ 50% reduction of 
symptoms; remission 
= PHQ < 5 or SCL < 
0.5.  Assessed at 8 & 
12 weeks. 
 
12 
months 
9 Hujbregts 3 Self-help book (all 
patients) plus PST (6 or 12 
sessions) or PST + ADM 
(patient preference) 
Self-help book, also 
switching treatments (PST 
/ ADs, patient preference) 
Referral to specialty 
mental health care 
- Depression Care 
Manager, GP, 
consultant 
psychiatrist 
PHQ-9 reduction <5 
and/or PHQ-9 score ≥ 
5 at 6 & 12 weeks. 
 
18 weeks 
4.5 
months 
10 Katon 3 1 vist + PST (6 sessions) or 
ADs (patient preference) 
Switching treatments, 
adding treatments, 
changing ADs and 
psychiatric consultation 
Referral to specialty 
mental health care 
- Nurses, psychiatrist PHQ-9 reduction < 
50% at 10-12 weeks 
then + 8-12 weeks. 
6 months  
11 Patel 4 Face-to-face PE ADs or IPT (6 to 12 
sessions) + adherence 
management 
ADs + IPT (6 to 12 
sessions) + adherence 
management 
Continue all 
treatments + referral 
to clinical specialist 
Lay health counselor 
(non-medical 
graduate),  GP, 
psychiatrist 
Routine clinical 
assessment  by the 
health counsellor.  
Time point not 
reported. 
 
6 months 
12 Seekles 3 PE (1 face-to-face session) 
+ bibliotherapy (content 
depending on diagnosis, 
online/telephone support 
on request) 
PST  (5 sessions) Contact with Care 
Manager (1 session): 
referral to GP or 
specialist mental health 
setting 
- Mental health nurse, 
junior psychologist 
IDS ≥ 14 or HADS-A  ≥ 
8 or WSAS ≥ 6 every 8 
weeks. 
18-24 
weeks  6 
months 
13 Unutzer 3 Videotape + booklet + 1 
DCM visit then PST (6 to 8 
sessions) or ADs (patient 
preference)  
Switching treatments, 
adding treatments, 
changing ADs (patient 
preference  
Team considered  
alternative treatment 
for each patient 
individually (e.g. 
hospitalisation) 
 
- Depression Care 
Manager (nurses, 
psychologist), 
psychiatrist, GP 
PHQ9 reduction <50% 
and more than 2 out 
of the 9 symptoms of 
MDD.  Assessed end 
step 1 (precise timing 
not reported) & after 
10 weeks step 2 
treatment. 
 
12 
months 
14 Van ‘t 
Veer 
3 Bibliotherapy (based on 
CWD; support by 
telephone calls or face-to-
face visits, no 
predetermined number) 
 
PST (7 sessions)  Referral to GP - Home care / 
community mental 
health nurse 
CES-D ≥16 every 3 
months. 
12 
months 
1 
Providers’ includes the role of all health care professionals involved in the stepped care intervention except for professionals who cared for patients ‘on referral’. 
Abbreviations: ADs=antidepressants; CBT = cognitive behavioral therapy; CDCS = cancer depression clinical specialist; CES-D = center for epidemiological studies 
depression scale; CGI-S= Clinical Global Impression Severity Scale; CWD = Coping with depression; HADS-A = Hospital Anxiety and depression scale-Anxiety; HDRS = 
Hamilton depression rating scale; IPT = interpersonal psychotherapy; MDD = major depressive disorder; PST = problem solving treatment; PE = psycho-education; WSAS 
= work and social adjustment scale 
Table 3 . Meta-analysis, and subgroup analysis, of 10 studies examining the effects of stepped care for 
depression compared to care-as-usual: effect sizes (Cohen’s d)  
Ncomp = number of comparisons; * = P < 0.01; CI = 95% confidence intervals; na = not applicable 
 
 
 Ncomp d 95% CI I
2
 P value 
Post intervention effect sizes 
 Outcomes combined 
 Outcomes with highest ES 
 Outcomes with lowest ES 
 
 
10 
10 
10 
 
0.38 
0.42 
0.33 
 
0.18 to 0.57 
0.22 to 0.62 
0.13 to 0.52 
 
81.53* 
81.33* 
84.81* 
 
Na 
Effect sizes for different time points 
(outcomes combined) 
 2-4 months 
 6 months 
 9-12 months 
 18 months 
 
 
 
4 
10 
5 
1 
 
 
 
0.57 
0.34 
0.43 
0.26 
 
 
 
0.21 to 0.94 
0.20 to 0.48 
0.20 to 0.65 
< - 0.01 to 0.53 
 
 
83.61* 
68.11* 
74.81* 
- 
 
 
 
Na 
Subgroup analysis on six months outcomes (d = 0.34; 95% CI 0.20 to 0.48) 
 
Country 
 USA 
 Netherlands 
 other 
 
6 
2 
2 
 
0.38 
0.18 
0.44 
 
0.29 to 0.46 
-0.22 to 0.58 
-0.31 to 1.19 
 
0.00 
33.54 
94.57* 
 
0.63 
IMPACT based 
 yes 
 no 
 
7 
3 
 
0.38 
0.31 
 
0.30 to 0.46 
-0.18 to 0.80 
 
0.00 
89.78* 
0.79 
Progressive treatment intensity? 
 yes 
 no 
 
2 
8 
 
0.07 
0.41 
 
-0.08 to 0.22 
0.33 to 0.49 
 
0.00 
44.03 
 
< 0.01 
Physical co-morbidity 
 Present 
 Absent 
 
5 
5 
 
0.32 
0.35 
 
0.19 to 0.44 
0.09 to 0.62 
 
0.00 
84.11* 
 
0.82 
Inclusion based on diagnosis 
 yes 
 no 
 
5 
5 
 
0.35 
0.32 
 
0.09 to 0.62 
0.19 to 0.44 
 
84.11* 
0.00 
 
0.82 
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Box 1. Key areas of future research on stepped care. 
 
 
Appropriately powered, non-inferiority randomised controlled trial of stepped care for depression 
and/or other disorders defined by a progressive increase in treatment intensity compared with a 
single-step high intensity psychological treatment; cost-effectiveness and process analysis of above 
to be included. 
 
Pilot research into defining a) stepping criteria (algorithm) for stepped care and b) stratification 
criteria for matched care, leading to an appropriately powered, non-inferiority randomised 
controlled trial of stepped care for depression and/or other disorders defined by a progressive 
increase in treatment intensity compared with a matched care control. 
 
Appropriately powered, non-inferiority randomised controlled trial of stepped care for depression 
defined by progressive intensity of psychological vs. stepped care defined by combined treatment 
modalities (psychological and pharmacological). 
 
Following more published trials, an updated systematic review of stepped care to help identify (via 
subgroup analysis) optimal components of stepped care.   
 
Additional randomised controlled trials to compare stepped care with other treatment for the 
prevention of depression. 
 
 
Box 1
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Box 2. Recommended reporting standards on stepped care 
 
Data to include in the report of a clinical trial on stepped care for depression 
 
Number of patients in stepped care and control group(s) 
Drop out prior to step one and between steps (n, %) 
Number, % of people discharged from treatment at each step 
Number, % of people stepping up to subsequent steps 
 
For each step: 
N treated 
Health care professionals involved 
Training and education provided to deliver clinical protocols 
Treatment received 
 n patients in receipt 
 dose e.g. n sessions of psychological therapy (mean, SD) 
 duration e.g. n weeks (mean, SD) 
Drop out of treatment during specific step (n, %) 
Patient outcomes on end of each treatment step 
 n patients’ health status assessed  
 depressive symptoms  (mean, SD, n in analysis) 
 n, % recovered or improved with definition of recovery / improvement specified 
 
Stepping criteria: 
Measure 
Frequency and timeframe of assessment  
Definition of improvement / recovery required to end treatment or to step 
 
For the control group: 
Number treated 
Treatment received (detail as above) 
Treatment drop out (n, %) 
Patient outcomes (detail as above) 
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